Eduardo Cheuiche Antonio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eduardo Cheuiche Antonio has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Gustavo Fioravanti Vieira
Universidade Federal do Rio Grande do Sul
3 shared publications - Bruna Bordignon Vian2 shared publications
Alexandre dos Santos Pereira
1 shared publication- Etiele de Senna Silveira
Programa de Pós-Graduação em Genética e Biologia Molecular, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 91501-970, Brazil
1 shared publication - Marcelo Alves de Souza Bragatte
Instituto Todos pela Saude ITpS, Sao Paulo, Brazil
1 shared publication - Mariana Rost Meireles
Institute of Technology for Food and Health (itt Nutrifor), Universidade Do Vale Do Rio Dos Sinos—Unisinos, São Leopoldo 93022-154, RS, Brazil
1 shared publication
Latest Publications
- Open Access
- 22 July 2026
- Published by Elsevier in SSRN Electronic Journal
Evaluating different pMHC modeling software by their capacity to reproduce cross-reactivity webs
T-cell cross-reactivity occurs when distinct peptide-MHC complexes are recognized by the same T-cell population, a phenomenon with important implications for vaccine design, cancer immunotherapy, and off-target immune responses. Since experimental structural determination of peptide-MHC complexes remains costly and time-consuming, computational modeling offers a practical alternative for investigating candidate cross-reactive epitopes. However, pMHC modeling methods are usually evaluated by structural similarity to crystallographic references rather than by their ability to reproduce known immunological cross-reactivity patterns. In this study, we compared DockTope, APE-GEN 2.0, AlphaFold3, and PANDORA according to their capacity to reproduce experimentally described cross-reactivity webs among HLA-A*02:01-restricted nonameric epitopes. Modeled pMHC structures were visualized in GRASP 2.0, and RGB values representing electrostatic potential in TCR-contacting regions were extracted to generate pairwise electrostatic-distance matrices. Depending on dataset structure, method performance was evaluated using ROC-AUC, relative compactness scores, or normalized discounted cumulative gain. Across the majority of the article-derived epitope sets, DockTope showed the strongest overall agreement with expected cross-reactivity behavior, achieving the highest composite score and best mean rank. APE-GEN 2.0 showed intermediate and dataset-dependent performance, while AlphaFold3 performed strongly in positive-only compactness datasets but less consistently when discrimination from non-reactive comparators was required. PANDORA showed the weakest overall agreement under this workflow. These findings suggest that pMHC modeling tools differ substantially in their ability to preserve TCR-facing electrostatic relationships relevant to cross-reactive recognition. Benchmarking pMHC models against immunological behavior, rather than structural accuracy alone, may improve computational prioritization of cross-reactive epitopes.
- 22 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEvaluating different pMHC modeling software by their capacity to reproduce cross-reactivity webs
T-cell cross-reactivity occurs when distinct peptide-MHC complexes are recognized by the same T-cell population, a phenomenon with important implications for vaccine design, cancer immunotherapy, and off-target immune responses. Since experimental structural determination of peptide-MHC complexes remains costly and time-consuming, computational modeling offers a practical alternative for investigating candidate cross-reactive epitopes. However, pMHC modeling methods are usually evaluated by structural similarity to crystallographic references rather than by their ability to reproduce known immunological cross-reactivity patterns. In this study, we compared DockTope, APE-GEN 2.0, AlphaFold3, and PANDORA according to their capacity to reproduce experimentally described cross-reactivity webs among HLA-A*02:01-restricted nonameric epitopes. Modeled pMHC structures were visualized in GRASP 2.0, and RGB values representing electrostatic potential in TCR-contacting regions were extracted to generate pairwise electrostatic-distance matrices. Depending on dataset structure, method performance was evaluated using ROC-AUC, relative compactness scores, or normalized discounted cumulative gain. Across the majority of the article-derived epitope sets, DockTope showed the strongest overall agreement with expected cross-reactivity behavior, achieving the highest composite score and best mean rank. APE-GEN 2.0 showed intermediate and dataset-dependent performance, while AlphaFold3 performed strongly in positive-only compactness datasets but less consistently when discrimination from non-reactive comparators was required. PANDORA showed the weakest overall agreement under this workflow. These findings suggest that pMHC modeling tools differ substantially in their ability to preserve TCR-facing electrostatic relationships relevant to cross-reactive recognition. Benchmarking pMHC models against immunological behavior, rather than structural accuracy alone, may improve computational prioritization of cross-reactive epitopes.
- Open Access
Chasing the Bigfoot: shared molecular patterns among pMHC-I differentiate self from non self peptides
The ability of T cells to discriminate self from non-self peptides is a cornerstone of adaptive immunity, yet the structural principles guiding this process remain poorly defined. Here, we present a proof-of-concept study using physicochemical descriptors derived from images of peptide-MHC (pMHC) surfaces to explore patterns of immunogenicity. We modeled 353 pMHC complexes restricted to HLA-A*02:01, comprising 106 self-derived peptides from the HLA Ligand Atlas and 247 viral epitopes from the Immune Epitope Database. Electrostatic potentials of TCR-facing interfaces were computed and transformed into quantitative features across 92 immunologically relevant regions of interest. Unsupervised hierarchical clustering uncovered subsets of pMHCs forming self-only, viral-only, and mixed clusters, revealing conserved structural fingerprints linked to tolerance or immunogenicity. Heatmap analysis identified close viral-self proximities, highlighting candidate pairs potentially involved in molecular mimicry and autoimmune triggers. Building on these findings, we trained an XGBoost classifier that achieved strong performance (F1 score 0.87; AUC 0.84) in distinguishing self from viral peptides. To our knowledge, this is the first demonstration that structural and physicochemical fingerprints of pMHC complexes are sufficient to discriminate self from non-self. These results establish a framework for computational immunology and provide hypotheses for validation, with implications for autoimmunity, vaccine design, and immunotherapy.
Open AccessChasing the Bigfoot: shared molecular patterns among pMHC-I differentiate self from non self peptides
The ability of T cells to discriminate self from non-self peptides is a cornerstone of adaptive immunity, yet the structural principles guiding this process remain poorly defined. Here, we present a proof-of-concept study using physicochemical descriptors derived from images of peptide-MHC (pMHC) surfaces to explore patterns of immunogenicity. We modeled 353 pMHC complexes restricted to HLA-A*02:01, comprising 106 self-derived peptides from the HLA Ligand Atlas and 247 viral epitopes from the Immune Epitope Database. Electrostatic potentials of TCR-facing interfaces were computed and transformed into quantitative features across 92 immunologically relevant regions of interest. Unsupervised hierarchical clustering uncovered subsets of pMHCs forming self-only, viral-only, and mixed clusters, revealing conserved structural fingerprints linked to tolerance or immunogenicity. Heatmap analysis identified close viral-self proximities, highlighting candidate pairs potentially involved in molecular mimicry and autoimmune triggers. Building on these findings, we trained an XGBoost classifier that achieved strong performance (F1 score 0.87; AUC 0.84) in distinguishing self from viral peptides. To our knowledge, this is the first demonstration that structural and physicochemical fingerprints of pMHC complexes are sufficient to discriminate self from non-self. These results establish a framework for computational immunology and provide hypotheses for validation, with implications for autoimmunity, vaccine design, and immunotherapy.
- Open Access
Can the protection be among us? Previous viral contacts and prevalent HLA alleles avoiding an even more disseminated COVID-19 pandemic
COVID-19 is bringing scenes of sci-fi movies into real life, and it seems to be far from over. Infected individuals exhibit variable severity, suggesting the involvement of the genetic constitution of populations and previous cross-reactive immune contacts in the individuals’ disease outcome. To investigate the participation of MHC alleles in COVID-19 severity, the combined use of HLA-B*07, HLA-B*44, HLA-DRB1*03, and HLA-DRB1*04 grouped affected countries presenting similar death rates, based only on their allele frequencies. To prospect T cell targets in SARS-CoV-2, we modeled 3D structures of HLA-A*02:01 complexed with immunogenic epitopes from SAR-CoV-1 and compared them with models containing the corresponding SARS-CoV-2 peptides. It reveals molecular conservation between SARS-CoV peptides, evidencing that the corresponding current sequences are putative T cell epitopes. These structures were also compared with other HCoVs sequences, and with a panel of epitopes from unrelated viruses, looking for the triggers of cross-protection in asymptomatic and uninfected individuals. 229E, OC43, and impressively, viruses involved in endemic human infections share fingerprints of immunogenicity with SARS-CoV peptides. Wide-scale HLA genotyping in COVID-19 patients shall improve prognosis prediction. Structural identification of previous triggers paves the way for herd immunity examination and wide spectrum vaccine development.
Open AccessCan the protection be among us? Previous viral contacts and prevalent HLA alleles avoiding an even more disseminated COVID-19 pandemic
COVID-19 is bringing scenes of sci-fi movies into real life, and it seems to be far from over. Infected individuals exhibit variable severity, suggesting the involvement of the genetic constitution of populations and previous cross-reactive immune contacts in the individuals’ disease outcome. To investigate the participation of MHC alleles in COVID-19 severity, the combined use of HLA-B*07, HLA-B*44, HLA-DRB1*03, and HLA-DRB1*04 grouped affected countries presenting similar death rates, based only on their allele frequencies. To prospect T cell targets in SARS-CoV-2, we modeled 3D structures of HLA-A*02:01 complexed with immunogenic epitopes from SAR-CoV-1 and compared them with models containing the corresponding SARS-CoV-2 peptides. It reveals molecular conservation between SARS-CoV peptides, evidencing that the corresponding current sequences are putative T cell epitopes. These structures were also compared with other HCoVs sequences, and with a panel of epitopes from unrelated viruses, looking for the triggers of cross-protection in asymptomatic and uninfected individuals. 229E, OC43, and impressively, viruses involved in endemic human infections share fingerprints of immunogenicity with SARS-CoV peptides. Wide-scale HLA genotyping in COVID-19 patients shall improve prognosis prediction. Structural identification of previous triggers paves the way for herd immunity examination and wide spectrum vaccine development.